supplied by www.ccc.ac.at

37 Einträge

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Autoren Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF
Erscheinungsdaten Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3
Publikations ID PMID: 26040499
 


Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Autoren Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Knauer M, Moik M, Jakesz R, Seifert M, Taucher S, Bjelic-Radisic V, Balic M, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Selim U, Fitzal F, Hochreiner G, Wette V, Sevelda P, Ploner F, Bartsch R, Fesl C, Greil R
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Nov 17. pii: mdu544. doi: 10.1093/annonc/mdu544
Publikations ID PMID: 25403582
 


Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Autoren Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt494. doi: 10.1093/annonc/mdt494
Publikations ID PMID: 24347518
 


The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Autoren Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R
Erscheinungsdaten British journal of cancer. 2013 Jul 18. pii: bjc2013367. doi: 10.1038/bjc.2013.367. pmc: PMC3738117
Publikations ID PMID: 23868011
 


Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Autoren Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M
Erscheinungsdaten British journal of cancer. 2013 Mar 19. pii: bjc2013114. doi: 10.1038/bjc.2013.114. pmc: PMC3629426
Publikations ID PMID: 23511562
 


Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
Autoren Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Jan 23. pii: JCO.2011.36.8993. doi: 10.1200/JCO.2011.36.8993
Publikations ID PMID: 22271481
 


Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
Autoren Bago-Horvath Z, Rudas M, Dubsky P, Jakesz R, Singer CF, Kemmerling R, Greil R, Jelen A, Böhm G, Jasarevic Z, Haid A, Gruber C, Pöstlberger S, Filipits M, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Oct 13. pii: 1078-0432.CCR-11-1846. doi: 10.1158/1078-0432.CCR-11-1846
Publikations ID PMID: 21998336
 


A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Autoren Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Aug 1. pii: 1078-0432.CCR-11-0926. doi: 10.1158/1078-0432.CCR-11-0926
Publikations ID PMID: 21807638
 


Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Autoren Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Heck D, Menzel C, Jakesz R, Seifert M, Hubalek M, Pristauz G, Bauernhofer T, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Hochreiner G, Forsthuber EP, Fesl C, Greil R
Erscheinungsdaten The Lancet. Oncology. 2011 Jun 5. pii: S1470-2045(11)70122-X. doi: 10.1016/S1470-2045(11)70122-X
Publikations ID PMID: 21641868
 


Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Autoren Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Sep 1. pii: 1078-0432.CCR-09-0728. doi: 10.1158/1078-0432.CCR-09-0728
Publikations ID PMID: 19723645
 


Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Autoren Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, Marth C
Erscheinungsdaten The New England journal of medicine. 2009 Feb 13. pii: 360/7/679. doi: 10.1056/NEJMoa0806285
Publikations ID PMID: 19213681
 


Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Autoren Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Apr 2. pii: 14/7/2082. doi: 10.1158/1078-0432.CCR-07-2068
Publikations ID PMID: 18381948
 


Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Autoren Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Mar 18. pii: 14/6/1767. doi: 10.1158/1078-0432.CCR-07-4122
Publikations ID PMID: 18347178
 


Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Autoren Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H
Erscheinungsdaten Journal of the National Cancer Institute. 2007 Dec 11. pii: djm246. doi: 10.1093/jnci/djm246
Publikations ID PMID: 18073378
 


Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
Autoren Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 May 21. pii: 25/15/2012. doi: 10.1200/JCO.2006.09.1777
Publikations ID PMID: 17513805
 


Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Autoren Pötter R, Gnant M, Kwasny W, Tausch C, Handl-Zeller L, Pakisch B, Taucher S, Hammer J, Luschin-Ebengreuth G, Schmid M, Sedlmayer F, Stierer M, Reiner G, Kapp K, Hofbauer F, Rottenfusser A, Pöstlberger S, Haider K, Draxler W, Jakesz R
Erscheinungsdaten International journal of radiation oncology, biology, physics. 2007 Mar 23. pii: S0360-3016(07)00064-8. doi: 10.1016/j.ijrobp.2006.12.045
Publikations ID PMID: 17363187
 


Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Autoren Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J
Erscheinungsdaten Lancet (London, England). 2005 Aug 8. pii: S0140-6736(05)67059-6. doi: 10.1016/S0140-6736(05)67059-6
Publikations ID PMID: 16084253
 


Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Autoren Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R
Erscheinungsdaten Thrombosis and haemostasis. 2003 Jun 3. doi: 10.1267/THRO03061098. pii: 03061098
Publikations ID PMID: 12783124
 


Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.
Autoren Scheithauer W, Schüll B, Ulrich-Pur H, Schmid K, Raderer M, Haider K, Kwasny W, Depisch D, Schneeweiss B, Lang F, Kornek GV
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2002 Dec 18.
Publikations ID PMID: 12488300
 


Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Autoren Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Jun 12.
Publikations ID PMID: 12060624
 


Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
Autoren Kornek GV, Haider K, Kwasny W, Raderer M, Schüll B, Payrits T, Depisch D, Kovats E, Lang F, Scheithauer W
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 May 13.
Publikations ID PMID: 12006518
 


Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.
Autoren Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Jun 18.
Publikations ID PMID: 11410505
 


Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.
Autoren Scheithauer W, Kornek GV, Ulrich-Pur H, Penz M, Raderer M, Salek T, Haider K, Kwasny W, Depisch D
Erscheinungsdaten Cancer. 2001 Apr 3. pii: 10.1002/1097-0142(20010401)91:7<1264::AID-CNCR1127>3.0.CO;2-X
Publikations ID PMID: 11283925
 


Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
Autoren Kornek GV, Ulrich-Pur H, Penz M, Haider K, Kwasny W, Depisch D, Kovats E, Lang F, Schneeweiss B, Scheithauer W
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Feb 22.
Publikations ID PMID: 11157011
 


A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.
Autoren Ulrich-Pur H, Kornek GV, Raderer M, Haider K, Kwasny W, Depisch D, Greul R, Schneeweiss B, Krauss G, Funovics J, Scheithauer W
Erscheinungsdaten Cancer. 2000 Sep 11. pii: 10.1002/1097-0142(20000601)88:11<2505::AID-CNCR11>3.0.CO;2-E
Publikations ID PMID: 10861426
 


Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Autoren Kornek GV, Schratter-Sehn A, Marczell A, Depisch D, Karner J, Krauss G, Haider K, Kwasny W, Locker G, Scheithauer W
Erscheinungsdaten British journal of cancer. 2000 Jan 31. pii: S0007092099908844. doi: 10.1054/bjoc.1999.0884. pmc: PMC2363209
Publikations ID PMID: 10638974
 


Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.
Autoren Scheithauer W, Kornek GV, Raderer M, Valencak J, Weinländer G, Hejna M, Haider K, Kwasny W, Depisch D
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Mar 16.
Publikations ID PMID: 10071282
 


Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
Autoren Kornek GV, Haider K, Kwasny W, Lang F, Krauss G, Hejna M, Raderer M, Weinländer G, Depisch D, Scheithauer W
Erscheinungsdaten British journal of cancer. 1998 Sep 24. pmc: PMC2063060
Publikations ID PMID: 9744509
 


Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
Autoren Kornek GV, Haider K, Kwasny W, Hejna M, Raderer M, Meghdadi S, Burger D, Schneeweiss B, Depisch D, Scheithauer W
Erscheinungsdaten British journal of cancer. 1996 Dec 27. pmc: PMC2074837
Publikations ID PMID: 8932353
 


Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma.
Autoren Scheithauer W, Kornek G, Rosen H, Sebesta C, Marcell A, Kwasny W, Karall M, Depisch D
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 1996 Mar 1.
Publikations ID PMID: 8562152
 


A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach.
Autoren Kornek G, Schulz F, Depisch D, Rosen H, Kwasny W, Sebesta C, Scheithauer W
Erscheinungsdaten Cancer. 1993 Apr 20.
Publikations ID PMID: 8453539
 


Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.
Autoren Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D
Erscheinungsdaten Breast cancer research and treatment. 1993 Nov 16.
Publikations ID PMID: 8400323
 


Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Autoren Singer CF, Filipits M, Jahn SW, Abete L, Jakesz R, Greil R, Bauernhofer T, Kwasny W, Seifert M, Fitzal F, Kastner M, Schmitt M, Moinfar F, Gnant M
Erscheinungsdaten Breast (Edinburgh, Scotland). 2019 May 3. pii: S0960-9776(19)30501-6. doi: 10.1016/j.breast.2019.05.007
Publikations ID PMID: 31132475
 


Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Autoren Fastner G, Sedlmayer F, Widder J, Metz M, Geinitz H, Kapp K, Fesl C, Sölkner L, Greil R, Jakesz R, Kwasny W, Heck D, Bjelic-Radisic V, Balic M, Stöger H, Wieder U, Zwrtek R, Semmler D, Horvath W, Melbinger-Zeinitzer E, Wiesholzer M, Wette V, Gnant M
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2020 Jan 18. pii: S0959-8049(19)30873-1. doi: 10.1016/j.ejca.2019.11.024
Publikations ID PMID: 31962198
 


Predictive value of molecular subtypes in premenopausal women with hormone receptor-positive early breast cancer: Results from the ABCSG Trial 5.
Autoren Bago-Horvath Z, Rudas M, Singer CF, Greil R, Balic M, Lax S, Kwasny W, Hulla W, Gnant M, Filipits M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Jun 16. pii: 1078-0432.CCR-20-0673. doi: 10.1158/1078-0432.CCR-20-0673
Publikations ID PMID: 32546648
 


Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Autoren Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R
Erscheinungsdaten The New England journal of medicine. doi: 10.1056/NEJMoa2104162
Publikations ID PMID: 34320285
 


Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Autoren Gampenrieder SP, Pircher M, Fesl C, Rinnerthaler G, Mlineritsch B, Greil-Ressler S, Steger GG, Sagaster V, Fitzal F, Exner R, Devyatko Y, Balic M, Stöger H, Suppan C, Bauernhofer T, Singer CF, Pfeiler G, Seifert M, Helfgott R, Heck D, Rumpold H, Kwasny W, Wieder U, Gnant M, Greil R
Erscheinungsdaten Breast care (Basel, Switzerland). 2021 May 21. doi: 10.1159/000516157. pii: brc-0017-0137. pmc: PMC9149458
Publikations ID PMID: 35707180